Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Joseph
Investments
Work Experience
2020
Partner
2020
Board Director
2009
F2G Ltd Aug 2022 - present Autolus Therapeutics Feb 2016 - present Algeta ASA 2009 - 2013 (acquired by Bayer) Amarin plc 2009 - 2013 Epigenomics Ag 2012 - 2014 Cytos Biotechnology Ag 2012 - 2016 (Merged with Kuros Bioscience AG)
2016 - 2020
Arix Bioscience plc, Cofounder, CEO and CIO
2016 - 2020
2004 - 2015
Partner
2004 - 2015
Partner at Abingworth, a leading life science investment firm with offices in the UK, California and Boston. Led investments in US and EU life science and healthcare companies, taking board seats where relevant and an active role in developing the businesses. Established and led the successful VIPE practice (venture investing in public equities). Also founded and co-managed Abingworth's public equities hedge fund with a 10 year track record of success.
1999 - 2003
Head of Global Healthcare Equities and Portfolio Manager
1999 - 2003
Led a team of analysts generating healthcare stock ideas for global equities portfolios across First State Group. Founded and managed the S&P A-rated Global Health and Biotechnology Fund.
1998 - 1999
Pharmaceuticals Analyst
1998 - 1999
Sell-side analyst responsible for European Pharmaceutical coverage. In depth thematic research notes as well as company specific reports and recommendations.
1990 - 1998
Head of Strategy Group
1990 - 1998
Led the strategy and policy research team, supporting the Board in developing strategy and promoting medical science globally. Member of the Wellcome Trust Management Committee.
1985 - 1989
Head of Research
1985 - 1989
Consultancy team specialising in analysis and advice on medical research and the healthcare industry for internal and external clients